Sumifun Pain Relief Creams Cream
NDC Package 87083-011-01
Package Information
Sumifun Pain Relief Creams (methyl saliclate capsaicin camphor) cream is directionsAdults and children 12 years of age and older:Rub a thin film over affected areas not more 4 times daily;Massage not necessaryChildren under 12 years of age:Consult physician;Wash hands after use with cool water. This formulation utilizes a cream delivery system. Marketed by Guchutang Biotechnology (longyan) Co., Ltd, this product is identified by NDC 87083-011 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2740835 - camphor 5 % / capsaicin 0.025 % / methyl salicylate 10 % Topical Cream
- RxCUI: 2740835 - camphor 50 MG/ML / capsaicin 0.25 MG/ML / methyl salicylate 100 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87083 - Guchutang Biotechnology (longyan) Co., Ltd
- 87083-011 - Sumifun Pain Relief Creams
- 87083-011-01 - 30 g in 1 BOTTLE
- 87083-011 - Sumifun Pain Relief Creams
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87083-011-01 identifies a specific commercial package of 30 g in 1 bottle of Sumifun Pain Relief Creams, a human over the counter drug labeled by Guchutang Biotechnology (longyan) Co., Ltd. This cream is formulated for topical use and contains camphor, (-)-; capsaicin; methyl salicylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guchutang Biotechnology (longyan) Co., Ltd on April 12, 2026. The current certification is valid through December 31, 2027.
How is this Guchutang Biotechnology (longyan) Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87083001101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.